Pain management
ID 117616170 © Designer491 | Dreamstime.com

This week there is a bit of executive-related gossip – officially denied – as well as value talk, governance risk and then insight from clients concerning WiseTech (WTC).

Sure thing: let’s start from the basics to end up with the bull thesis.

Where it stands, shakily… 

Sift through the trading multiples sourced from S&P Capital IQ estimates, and WTC hasn’t been this cheap for a decade ever since the business was IPO’d, based on forward 12-month revenue (8.8x), Ebit (27x), and Ebitda (20.5x) ...

Daily News from £12 / mo  ·  includes Daily News

Comment on this article


You must be logged in to post a comment.